About Us

Juno Pharmaceuticals is a rapidly-growing global specialty pharmaceutical company that was founded in 2011 by group of experienced international pharmaceutical executives.

To date we have launched a wide range of differentiated generic and branded pharmaceutical products in our territories, with approvals pending for an extended list of additional products.

Our product portfolio and pipeline covers a broad spectrum of therapeutic areas and formats, including oral solid dosages, injectable medications, suspensions, ophthalmic solutions, creams and patches.

History

Juno at a Glance

If you would like to discuss a business opportunity with Juno, please contact Jesse Buckstein, Director of Corporate Development today.

Email: Jesse Buckstein

Our Businesses

Please roll over the logos or map points for further information

 

Our Capabilities

Global acquisition and in-licensing of specialty generic and branded pharmaceuticals and biologics, including mature brands and first-to-market generics. We utilize our access to medical specialists to identify key therapeutic needs/opportunities across our territories and leverage a global network of industry contacts to source ideal product development and supply partners.

Veteran regulatory affairs professionals with decades of industry experience. We have excellent relationships with the likes of the European Medicines Agency (EMA), the American Food and Drug Administration (FDA), Canada’s Therapeutic Products Directorate (TPD), Australia’s Therapeutic Goods Administration (TGA), and South Africa’s Medicines Control Council (MCC) and our team specializes in developing creative product submission strategies that reliably facilitate rapid market access for in-licensed products.

Numerous employees throughout our territories dedicated to reliably coordinating the movement of our products from point of origin to consumption.

Expert management of hospital tenders and retail relationships coupled with the development and successfully execution of novel product commercialization and reimbursement strategies.

In house IP experts who specialize in the evaluation of brand patent landscapes and the development of novel non-infringement and/or patent invalidation strategies.

“Juno will become a prominent international pharmaceutical company that supplies value-added and differentiated specialty products to global markets. Juno will build bridges to unmet medical needs through disciplined investment and successful application of creative business principles, ensuring that its customers and patient groups have access to the medicines they need at all times.”

Our Team

.

Ian Jacobson
Chief Executive Officer
View Full Bio

Mark Roberts
Chief Operating Officer
View Full Bio

Craig Podolsky
Chief Financial Officer
View Full Bio

.

.

Jon May
Business Development Director
View Full Bio

Andrew Brown
Head of Intellectual Property
View Full Bio

Jesse Buckstein
Director of Corporate Development
View Full Bio

.

.

Richard Jacques Ph.D.
Business Development Manager
View Full Bio

CVS Murthy
General Manager India
View Full Bio

Nandkishor Karekar
Supply Chain Manager
View Full Bio

.

.

News

Contact

Head Office:

Juno Pharmaceuticals Inc.
555 Richmond Street West, Suite 1004, Toronto,
Ontario M5V 3B1, Canada

+1 905 881 4410 Ext 203

Email: Jesse Buckstein

Business Development:

Juno Pharmaceuticals Inc.
1st Floor, The Coach House, Cross Heyes,
Malmesbury SN16 9BE

+44 (0) 1666 848 450

Email: UK Office